Core Historical Balance Sheet

CLB Stock

USD 21.28 0.16 0.76%

Trend analysis of Core Laboratories NV balance sheet accounts such as Short Long Term Debt Total of 220.2 M, Other Current Liabilities of 46.5 M or Total Current Liabilities of 100.6 M provides information on Core Laboratories' total assets, liabilities, and equity, which is the actual value of Core Laboratories to its prevalent stockholders. By breaking down trends over time using Core Laboratories balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Core Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Core Laboratories is a good buy for the upcoming year.

Core Laboratories Inventory

39.67 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Core Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Core Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Core Laboratories Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Core Laboratories and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Core currently owns. An asset can also be divided into two categories, current and non-current.

Core Laboratories Balance Sheet Chart

At present, Core Laboratories' Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 46.5 M, whereas Total Assets are forecasted to decline to about 550.2 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Core Laboratories assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Core Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Core Laboratories balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Core Laboratories NV are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Core Laboratories' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Core Laboratories current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	250.3M	222.4M	215.4M	220.2M
Total Assets	580.9M	578.4M	586.4M	550.2M

Short Long Term Debt Total Total Assets

Core Laboratories balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		0.81	0.59	0.86	0.41	0.82	0.8	0.52	0.7	0.54	0.93	-0.15	0.54	0.73	0.54	0.85	0.68	0.75	-0.29	0.9	0.23	0.82	0.34	0.44	0.84	0.57
Short Long Term Debt Total	0.81		0.61	0.65	-0.18	0.74	1.0	0.37	0.34	0.44	0.81	-0.29	0.44	0.53	0.17	0.99	0.36	0.64	-0.45	0.98	0.06	0.58	0.44	0.51	0.52	0.51
Other Current Liab	0.59	0.61		0.81	-0.09	0.25	0.55	0.86	0.62	0.71	0.38	0.07	0.71	0.84	0.18	0.62	0.16	0.49	-0.83	0.7	-0.09	0.76	0.2	0.22	0.45	0.47
Total Current Liabilities	0.86	0.65	0.81		0.31	0.52	0.6	0.81	0.91	0.82	0.63	-0.02	0.82	0.93	0.57	0.68	0.56	0.77	-0.6	0.79	0.04	0.96	0.05	0.21	0.8	0.66
Total Stockholder Equity	0.41	-0.18	-0.09	0.31		0.31	-0.17	0.13	0.52	0.09	0.36	0.11	0.09	0.28	0.67	-0.11	0.66	0.18	0.33	-0.02	0.31	0.37	-0.1	0.03	0.57	0.1
Property Plant And Equipment Net	0.82	0.74	0.25	0.52	0.31		0.77	0.08	0.3	0.26	0.91	-0.39	0.26	0.32	0.5	0.77	0.65	0.49	0.04	0.76	0.3	0.45	0.45	0.32	0.69	0.43
Net Debt	0.8	1.0	0.55	0.6	-0.17	0.77		0.31	0.3	0.38	0.82	-0.34	0.38	0.48	0.19	0.99	0.37	0.62	-0.41	0.96	0.05	0.53	0.42	0.54	0.5	0.51
Retained Earnings	0.52	0.37	0.86	0.81	0.13	0.08	0.31		0.77	0.75	0.21	0.21	0.75	0.94	0.28	0.38	0.23	0.55	-0.84	0.5	-0.07	0.86	-0.16	0.17	0.43	0.4
Accounts Payable	0.7	0.34	0.62	0.91	0.52	0.3	0.3	0.77		0.76	0.44	0.08	0.76	0.89	0.66	0.39	0.6	0.69	-0.47	0.52	0.0	0.92	-0.13	0.07	0.75	0.58
Cash	0.54	0.44	0.71	0.82	0.09	0.26	0.38	0.75	0.76		0.26	0.1	1.0	0.81	0.56	0.44	0.44	0.48	-0.67	0.55	-0.05	0.82	-0.11	-0.11	0.67	0.56
Non Current Assets Total	0.93	0.81	0.38	0.63	0.36	0.91	0.82	0.21	0.44	0.26		-0.32	0.26	0.45	0.42	0.85	0.59	0.62	-0.04	0.85	0.23	0.55	0.5	0.53	0.71	0.51
Non Currrent Assets Other	-0.15	-0.29	0.07	-0.02	0.11	-0.39	-0.34	0.21	0.08	0.1	-0.32		0.1	0.18	-0.18	-0.33	0.14	-0.31	0.05	-0.28	0.66	0.15	-0.1	-0.42	0.13	-0.68
Cash And Short Term Investments	0.54	0.44	0.71	0.82	0.09	0.26	0.38	0.75	0.76	1.0	0.26	0.1		0.81	0.56	0.44	0.44	0.48	-0.67	0.55	-0.05	0.82	-0.11	-0.11	0.67	0.56
Net Receivables	0.73	0.53	0.84	0.93	0.28	0.32	0.48	0.94	0.89	0.81	0.45	0.18	0.81		0.47	0.55	0.48	0.67	-0.72	0.66	0.06	0.97	-0.04	0.2	0.67	0.48
Common Stock Shares Outstanding	0.54	0.17	0.18	0.57	0.67	0.5	0.19	0.28	0.66	0.56	0.42	-0.18	0.56	0.47		0.23	0.78	0.39	-0.1	0.31	-0.01	0.57	-0.26	-0.07	0.77	0.55
Non Current Liabilities Total	0.85	0.99	0.62	0.68	-0.11	0.77	0.99	0.38	0.39	0.44	0.85	-0.33	0.44	0.55	0.23		0.38	0.68	-0.44	0.99	0.03	0.6	0.46	0.53	0.56	0.57
Inventory	0.68	0.36	0.16	0.56	0.66	0.65	0.37	0.23	0.6	0.44	0.59	0.14	0.44	0.48	0.78	0.38		0.35	0.07	0.44	0.49	0.64	0.02	-0.03	0.86	0.18
Other Current Assets	0.75	0.64	0.49	0.77	0.18	0.49	0.62	0.55	0.69	0.48	0.62	-0.31	0.48	0.67	0.39	0.68	0.35		-0.43	0.74	-0.14	0.73	0.04	0.31	0.54	0.68
Other Stockholder Equity	-0.29	-0.45	-0.83	-0.6	0.33	0.04	-0.41	-0.84	-0.47	-0.67	-0.04	0.05	-0.67	-0.72	-0.1	-0.44	0.07	-0.43		-0.5	0.43	-0.6	0.17	-0.24	-0.12	-0.48
Total Liab	0.9	0.98	0.7	0.79	-0.02	0.76	0.96	0.5	0.52	0.55	0.85	-0.28	0.55	0.66	0.31	0.99	0.44	0.74	-0.5		0.03	0.71	0.4	0.49	0.64	0.62
Property Plant And Equipment Gross	0.23	0.06	-0.09	0.04	0.31	0.3	0.05	-0.07	0.0	-0.05	0.23	0.66	-0.05	0.06	-0.01	0.03	0.49	-0.14	0.43	0.03		0.16	0.29	-0.31	0.41	-0.61
Total Current Assets	0.82	0.58	0.76	0.96	0.37	0.45	0.53	0.86	0.92	0.82	0.55	0.15	0.82	0.97	0.57	0.6	0.64	0.73	-0.6	0.71	0.16		-0.02	0.15	0.79	0.5
Short Term Debt	0.34	0.44	0.2	0.05	-0.1	0.45	0.42	-0.16	-0.13	-0.11	0.5	-0.1	-0.11	-0.04	-0.26	0.46	0.02	0.04	0.17	0.4	0.29	-0.02		0.14	0.17	0.0
Intangible Assets	0.44	0.51	0.22	0.21	0.03	0.32	0.54	0.17	0.07	-0.11	0.53	-0.42	-0.11	0.2	-0.07	0.53	-0.03	0.31	-0.24	0.49	-0.31	0.15	0.14		-0.04	0.37
Common Stock Total Equity	0.84	0.52	0.45	0.8	0.57	0.69	0.5	0.43	0.75	0.67	0.71	0.13	0.67	0.67	0.77	0.56	0.86	0.54	-0.12	0.64	0.41	0.79	0.17	-0.04		0.42
Common Stock	0.57	0.51	0.47	0.66	0.1	0.43	0.51	0.4	0.58	0.56	0.51	-0.68	0.56	0.48	0.55	0.57	0.18	0.68	-0.48	0.62	-0.61	0.5	0.0	0.37	0.42

Click cells to compare fundamentals

Core Laboratories Account Relationship Matchups

Core Laboratories balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	774.7M	568.6M	580.9M	578.4M	586.4M	550.2M
Short Long Term Debt Total	381.8M	327.0M	250.3M	222.4M	215.4M	220.2M
Other Current Liab	50.8M	34.9M	28.5M	31.8M	37.1M	46.5M
Total Current Liabilities	111.6M	89.8M	90.8M	103.1M	88.1M	100.6M
Total Stockholder Equity	182.1M	75.6M	161.0M	189.0M	224.8M	131.8M
Property Plant And Equipment Net	199.2M	181.7M	172.3M	157.4M	153.5M	120.1M
Net Debt	370.7M	313.2M	232.6M	207.0M	200.3M	187.0M
Retained Earnings	160.5M	50.5M	68.3M	85.9M	120.8M	194.2M
Accounts Payable	35.6M	23.0M	29.7M	45.8M	33.5M	35.9M
Cash	11.1M	13.8M	17.7M	15.4M	15.1M	14.4M
Non Current Assets Total	553.4M	402.7M	391.8M	366.7M	363.3M	325.2M
Non Currrent Assets Other	(71.3M)	(76.9M)	(74.6M)	(73.0M)	98.6M	103.5M
Cash And Short Term Investments	11.1M	13.8M	17.7M	15.4M	15.1M	14.4M
Net Receivables	131.6M	83.2M	96.8M	106.9M	123.1M	129.1M
Common Stock Shares Outstanding	44.6M	45.0M	46.7M	46.8M	47.5M	40.8M
Liabilities And Stockholders Equity	774.7M	568.6M	580.9M	578.4M	586.4M	550.2M
Non Current Liabilities Total	480.9M	403.3M	329.1M	286.3M	268.5M	267.2M
Inventory	50.2M	38.2M	45.4M	60.4M	71.7M	39.7M
Other Current Assets	28.4M	30.7M	29.1M	28.9M	13.2M	26.0M
Other Stockholder Equity	26.8M	27.1M	97.0M	100.9M	108.6M	114.0M
Total Liab	592.5M	493.0M	419.9M	389.4M	356.6M	367.8M
Property Plant And Equipment Gross	199.2M	181.7M	172.3M	157.4M	469.3M	492.7M
Total Current Assets	221.2M	165.8M	189.1M	211.7M	223.1M	225.0M
Accumulated Other Comprehensive Income	(6.3M)	(7.2M)	(10.1M)	(3.8M)	(5.0M)	(5.2M)
Short Term Debt	11.8M	11.4M	12.3M	11.7M	10.2M	14.1M
Intangible Assets	17.5M	8.6M	8.1M	7.5M	6.9M	6.6M
Other Liab	109.9M	87.7M	91.1M	75.6M	86.9M	66.4M
Other Assets	119.4M	179.4M	107.7M	102.3M	1.0	0.95
Long Term Debt	305.3M	259.4M	188.6M	172.4M	163.1M	227.7M
Property Plant Equipment	123.5M	115.3M	172.3M	157.4M	181.0M	126.1M
Current Deferred Revenue	13.4M	5.5M	7.8M	5.9M	4.8M	4.5M
Treasury Stock	(29.4M)	(14.1M)	(4.1M)	(1.4M)	(1.6M)	(1.6M)
Net Tangible Assets	11.7M	19.6M	(58.5M)	115.6M	104.1M	109.3M
Noncontrolling Interest In Consolidated Entity	4.3M	4.1M	4.6M	4.7M	5.4M	4.6M
Retained Earnings Total Equity	160.5M	50.5M	68.3M	85.9M	77.4M	73.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:

How To Invest In Core

Details

Is Core Stock a good investment?

Details

What is Core Laboratories' Net Worth?

Details

Largest Oil & Gas Equipment & Services Companies

View

Largest Energy Companies

View

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.316

Dividend Share

0.04

Earnings Share

0.54

Revenue Per Share

11.158

Quarterly Revenue Growth

0.072

The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Core Historical Balance Sheet

Core Laboratories Inventory

39.67 Million

About Core Balance Sheet Analysis

Core Laboratories Balance Sheet Chart

Total Assets

Total Current Liabilities

Core Laboratories balance sheet Correlations

Core Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Core Laboratories balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Non Current Liabilities Total	+ 0.99	Net Debt
Total Liab	+ 0.99	Non Current Liabilities Total
Total Liab	+ 0.98	Short Long Term Debt Total

Other Stockholder Equity	- 0.84	Retained Earnings
Other Stockholder Equity	- 0.83	Other Current Liab
Other Stockholder Equity	- 0.72	Net Receivables
Common Stock	- 0.68	Non Currrent Assets Other
Other Stockholder Equity	- 0.67	Cash And Short Term Investments
Other Stockholder Equity	- 0.67	Cash